Resmed Inc
Exchange: NYSESector: HealthcareIndustry: Medical Instruments & Supplies
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.
Did you know?
Earnings per share grew at a 23.0% CAGR.
Current Price
$209.43
+2.15%GoodMoat Value
$331.31
58.2% undervaluedProfile
Valuation (TTM)
Market Cap$30.51B
P/E20.08
EV$32.71B
P/B5.11
Shares Out145.68M
P/Sales5.51
Revenue$5.54B
EV/EBITDA13.90
Resmed Inc (RMD) Stock News
RMD Stock News & Headlines
Latest stock news and headlines for Resmed Inc (RMD). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $209.43. Market cap: $30.51B. Sector: Healthcare. Industry: Medical Instruments & Supplies. This page aggregates the latest news articles relevant to RMD from financial news sources, helping investors stay current on events that may impact Resmed Inc's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Resmed Inc (RMD).